CORRESP Filing
Tevogen Bio Holdings Inc.
Date: June 24, 2025 · CIK: 0001860871 · Accession: 0001641172-25-016299
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-288218
Letter
Tevogen Bio Holdings Inc.
Independence Boulevard, Suite #210
Warren, New Jersey 07059
June 24, 2025
VIA EDGAR
United States Securities and Exchange Commission
F Street, NE
Washington, D.C. 20549
Re: Tevogen Bio Holdings Inc.
Registration Statement on Form S-3
Filed June 20, 2025
File No. 333-288218
Request for Acceleration of Effectiveness
To the addressee above:
Pursuant to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended, Tevogen Bio Holdings Inc. hereby requests that the Securities and Exchange Commission accelerate the effectiveness of the above-referenced Registration Statement on Form S-3 (the "Registration Statement") and declare the Registration Statement effective as of 4:30 p.m., Eastern Time, on June 26, 2025, or as soon thereafter as possible.
Please feel free to direct any questions or comments concerning this request to Nick Hoover of Hogan Lovells US LLP at (410) 659-2790, and once the Registration Statement has been declared effective, please notify Mr. Hoover by calling him at the same phone number.
Sincerely,
Tevogen Bio Holdings Inc.
Show Raw Text
CORRESP 1 filename1.htm Tevogen Bio Holdings Inc. 15 Independence Boulevard, Suite #210 Warren, New Jersey 07059 June 24, 2025 VIA EDGAR United States Securities and Exchange Commission 100 F Street, NE Washington, D.C. 20549 Re: Tevogen Bio Holdings Inc. Registration Statement on Form S-3 Filed June 20, 2025 File No. 333-288218 Request for Acceleration of Effectiveness To the addressee above: Pursuant to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended, Tevogen Bio Holdings Inc. hereby requests that the Securities and Exchange Commission accelerate the effectiveness of the above-referenced Registration Statement on Form S-3 (the "Registration Statement") and declare the Registration Statement effective as of 4:30 p.m., Eastern Time, on June 26, 2025, or as soon thereafter as possible. Please feel free to direct any questions or comments concerning this request to Nick Hoover of Hogan Lovells US LLP at (410) 659-2790, and once the Registration Statement has been declared effective, please notify Mr. Hoover by calling him at the same phone number. Sincerely, Tevogen Bio Holdings Inc. /s/ Ryan Saadi By: Ryan Saadi Title: Chief Executive Officer and Chairperson of the Board of Directors